middle.news
Radiopharm Secures $8M Placement, Advances Brain Metastases Imaging and HER2 Therapy
6:03am on Monday 2nd of June, 2025 AEST
•
Healthcare
Read Story
Radiopharm Secures $8M Placement, Advances Brain Metastases Imaging and HER2 Therapy
6:03am on Monday 2nd of June, 2025 AEST
Key Points
Lantheus Holdings increases stake to 12.16% via $8M placement
RAD 101 shows effective detection of brain metastases using PET-mpMRI
RAD202 demonstrates strong tumor targeting and therapeutic potential in preclinical studies
Cash position improved to $36.86 million, supporting clinical pipeline through June 2026
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Radiopharm Theranostics (ASX:RAD)
OPEN ARTICLE